American Century Companies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-726,193
Closed -$5.19M 2980
2024
Q2
$5.19M Buy
726,193
+713,523
+5,632% +$5.46M ﹤0.01% 1499
2024
Q1
$84.9K Buy
+12,670
New +$87.2K ﹤0.01% 2877
2023
Q3
Sell
-609,685
Closed -$8.52M 2898
2023
Q2
$8.52M Buy
609,685
+391,365
+179% +$6.67M 0.01% 1124
2023
Q1
$4.1M Buy
+218,320
New +$3.59M ﹤0.01% 1334

Other funds holding CDMO

American Century Companies's CDMO Position: Q3 2024 in Review

American Century Companies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 726,193 shares — an estimated $5.19M sold.

American Century Companies first reported a position in CDMO in Q1 2023 and held it in 4 quarters. The position peaked at $8.52M in Q2 2023. 172 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • American Century Companies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 726,193 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $5.19M.
  • American Century Companies first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • American Century Companies's Avid Bioservices, Inc. Common Stock position peaked at $8.52M in Q2 2023.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.